DEXCOM INC

NASDAQ: DXCM (DexCom, Inc.)

最近更新时间: 06 Jan, 4:38PM

69.89

2.24 (3.31%)

前收盘价格 67.65
收盘价格 67.65
成交量 3,966,079
平均成交量 (3个月) 5,795,374
市值 27,407,730,688
市盈率 (P/E TTM) 38.83
预期市盈率 (P/E Forward) 28.57
价格/销量 (P/S) 6.39
股市价格/股市净资产 (P/B) 10.13
52周波幅
54.11 (-22%) — 93.25 (33%)
利润日期 30 Oct 2025
营业毛利率 12.90%
营业利益率 (TTM) 12.91%
稀释每股收益 (EPS TTM) 1.33
季度收入增长率 (YOY) 12.50%
季度盈利增长率 (YOY) -28.00%
总债务/股东权益 (D/E MRQ) 113.97%
流动比率 (MRQ) 1.50
营业现金流 (OCF TTM) 964.10 M
杠杆自由现金流 (LFCF TTM) 509.04 M
资产报酬率 (ROA TTM) 5.97%
股东权益报酬率 (ROE TTM) 23.72%

市场趋势

短期 中期
行业 Medical Devices (US) 混合的 混合的
Medical Devices (全球的) 混合的 混合的
股票 DexCom, Inc. 看跌 看跌

AIStockmoo 评分

-0.3
分析师共识 -0.5
内部交易活动 3.0
价格波动 -2.0
技术平均移动指标 -2.5
技术振荡指标 0.5
平均 -0.30

相关股票

股票 市值 DY P/E(TTM) P/B
DXCM 27 B - 38.83 10.13
PODD 21 B - 86.12 13.04
SSII 1 B - - 20.66
IRTC 6 B - - 42.64
TMDX 5 B - 55.88 13.56
ESTA 2 B - - 122.85

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

部门 Healthcare
行业 Medical Devices
投资方式 Mid Growth
内部持股比例 0.42%
机构持股比例 97.10%
52周波幅
54.11 (-22%) — 93.25 (33%)
目标价格波幅
68.00 (-2%) — 90.00 (28%)
90.00 (Argus Research, 28.77%) 购买
77.00 (10.17%)
68.00 (Evercore ISI Group, -2.70%) 保留
平均值 77.86 (11.40%)
总计 5 购买, 1 保留, 1 卖出
平均价格@调整类型 64.89
公司 日期 目标价格 调整类型 价格@调整类型
Barclays 12 Jan 2026 71.00 (1.59%) 卖出 70.98
Bernstein 09 Jan 2026 86.00 (23.05%) 购买 67.40
Mizuho 17 Dec 2025 78.00 (11.60%) 购买 65.75
Citigroup 11 Dec 2025 77.00 (10.17%) 购买 68.94
Morgan Stanley 02 Dec 2025 75.00 (7.31%) 购买 64.45
10 Nov 2025 63.00 (-9.86%) 保留 54.84
Evercore ISI Group 25 Nov 2025 68.00 (-2.70%) 保留 61.69
Argus Research 07 Nov 2025 90.00 (28.77%) 购买 55.00
名称 平均购买 ($) 平均卖出 ($) 总净额 总净值 ($)
BROWN MICHAEL JON 74.00 74.00 4,470 330,780
LEACH JACOB STEVEN 74.00 74.00 5,252 388,648
SAYER KEVIN R 74.00 74.00 36,961 2,735,114
STERN SADIE 74.00 74.00 4,467 330,558
SYLVAIN JEREME M 74.00 74.00 4,471 330,854
累积净数量 55,621
累积净值 ($) 4,115,954
累积平均购买 ($) 74.00
累积平均卖出 ($) 74.00
名称 持有人 日期 类型 数量 价格 价值 ($)
SAYER KEVIN R 职员 29 Jan 2026 获得 (+) 71,218 74.00 5,270,132
SAYER KEVIN R 职员 29 Jan 2026 处理 (-) 34,257 74.00 2,535,018
SYLVAIN JEREME M 职员 29 Jan 2026 获得 (+) 7,123 74.00 527,102
SYLVAIN JEREME M 职员 29 Jan 2026 处理 (-) 2,652 74.00 196,248
BROWN MICHAEL JON 职员 29 Jan 2026 获得 (+) 7,123 74.00 527,102
BROWN MICHAEL JON 职员 29 Jan 2026 处理 (-) 2,653 74.00 196,322
STERN SADIE 职员 29 Jan 2026 获得 (+) 7,123 74.00 527,102
STERN SADIE 职员 29 Jan 2026 处理 (-) 2,656 74.00 196,544
LEACH JACOB STEVEN 职员 29 Jan 2026 获得 (+) 8,310 74.00 614,940
LEACH JACOB STEVEN 职员 29 Jan 2026 处理 (-) 3,058 74.00 226,292
日期 类型 细节
04 Feb 2026 公告 Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
27 Jan 2026 公告 Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.
12 Jan 2026 公告 Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
07 Jan 2026 公告 Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
26 Dec 2025 公告 Latest SueWallSt Podcast: What DXCM Investors Need to Know About the Lawsuit
23 Dec 2025 公告 Tune Into the SueWallSt Podcast: DexCom, Inc. (DXCM) Lawsuit Explained
22 Dec 2025 公告 Shareholders SueWallSt in New Class Action Against DexCom, Inc. - Act Now
19 Dec 2025 公告 Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations
18 Dec 2025 公告 DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast
17 Dec 2025 公告 Latest SueWallSt Podcast: What DXCM Investors Need to Know About the Lawsuit
16 Dec 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
15 Dec 2025 公告 Shareholders SueWallSt in New Class Action Against DexCom, Inc. - Act Now
15 Dec 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
12 Dec 2025 公告 SueWallSt Podcast Explains Class Action Against DexCom, Inc. (DXCM)
11 Dec 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
09 Dec 2025 公告 Shareholders SueWallSt in New Class Action Against DexCom, Inc. - Act Now
09 Dec 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
09 Dec 2025 公告 DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast
08 Dec 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
08 Dec 2025 公告 DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast
05 Dec 2025 公告 SueWallSt Podcast Series Launches With Focus on DexCom, Inc. (DXCM) Fraud Allegations
05 Dec 2025 公告 Shareholders SueWallSt in New Class Action Against DexCom, Inc. - Act Now
04 Dec 2025 公告 Shareholders SueWallSt in New Class Action Against DexCom, Inc. - Act Now
04 Dec 2025 公告 Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy
04 Dec 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
03 Dec 2025 公告 Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations
02 Dec 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
02 Dec 2025 公告 Tune Into the SueWallSt Podcast: DexCom, Inc. (DXCM) Lawsuit Explained
01 Dec 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
01 Dec 2025 公告 Tune Into the SueWallSt Podcast: DexCom, Inc. (DXCM) Lawsuit Explained
25 Nov 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
25 Nov 2025 公告 GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program
24 Nov 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
20 Nov 2025 公告 Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States
20 Nov 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
19 Nov 2025 公告 Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes
18 Nov 2025 公告 Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations
18 Nov 2025 公告 DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
17 Nov 2025 公告 Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations
14 Nov 2025 公告 Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day
06 Nov 2025 公告 Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)
06 Nov 2025 公告 Shareholders SueWallSt in New Class Action Against DexCom, Inc. - Act Now
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票